Filing Flows › Tactile Systems Technology (TCMD) › Guidance & outlook
Tactile Systems Technology (TCMD) guidance and outlook
Tactile Systems Technology (TCMD) raised its guidance on Nov 2, 2026: Revenue $360M–$366M for FY2026; Revenue +9% to +11% for FY2026; EBITDA $50.0M–$52.0M for FY2026. Tactile Systems Technology's 10-Q filed Nov 2, 2026 makes 6 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $360M–$366M | reaffirmed |
| Revenue | FY2026 | +9% to +11% | reaffirmed |
| EBITDA | FY2026 | $50.0M–$52.0M | raised |
From the earnings release filed Nov 2, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 2, 2026
- Nimbl has replaced most orders for our Entre system and we expect it will continue to do so.
- In exchange for these rights, we made a $3.0 million upfront payment in the second quarter of 2026, which was recorded as an intangible asset and will be amortized on a straight-line basis beginning on the date the product is commercially available for sale, which is expected to be in the fourth quarter of 2026.
- We employ a small group of respiratory specialists, who educate DME representatives, provide product demonstrations for targeted clinicians and support technical questions related to the AffloVest.
- IT-related expenses reflected in both R&D expenses and Reimbursement, general and administrative expenses in both periods primarily related to the ongoing implementation of new technology across the entire order process, replacing legacy systems, which we expect to continue through the remainder of 2026.
- The timing and number of shares to be purchased will be based on the price of the Company's common stock, general business and market conditions and other investment considerations and factors.
- Historically, we have experienced increases in our expenditures consistent with the growth in our revenue, operations and personnel, and we anticipate that our expenditures will continue to increase as we expand our business.
Tactile Systems Technology's latest quarter
Tactile Systems Technology, Q3 2026: revenue $91.9M (+7% year over year), operating margin 10.4%, net earnings $7.2M, operating cash flow $12.0M. The chart follows the revenue to costs, profit and cash.
Questions
Did Tactile Systems Technology raise or lower its guidance?
Tactile Systems Technology (TCMD) raised its guidance on Nov 2, 2026: Revenue $360M–$366M for FY2026; Revenue +9% to +11% for FY2026; EBITDA $50.0M–$52.0M for FY2026.
What does Tactile Systems Technology expect?
Nimbl has replaced most orders for our Entre system and we expect it will continue to do so. In exchange for these rights, we made a $3.0 million upfront payment in the second quarter of 2026, which was recorded as an intangible asset and will be amortized on a straight-line basis beginning on the date the product is commercially available for sale, which is expected to be in the fourth quarter of 2026. We employ a small group of respiratory specialists, who educate DME representatives, provide product demonstrations for targeted clinicians and support technical questions related to the AffloV
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.